Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Diagnostic performance of the PCA3 urine test

Nature Reviews Urology volume 8, pages 123–124 (2011)Cite this article

Subjects

The potential of the prostate cancer antigen 3 (PCA3) urine assay to aid prostate cancer diagnosis and minimize unnecessary biopsies has been extensively studied. Results from three recent studies that compared the performance of PCA3 with PSA underscore the advancement and future challenges for this new diagnostic biomarker.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ploussard, G. & de la Taille, A. Urine biomarkers in prostate cancer. Nat. Rev. Urol. 7, 101–109 (2010).

    Article  CAS  PubMed  Google Scholar 

  2. Bussemakers, M. J. et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 59, 5975–5979 (1999).

    CAS  PubMed  Google Scholar 

  3. Hessels, D. et al. DD3 (PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur. Urol. 44, 8–15 (2003).

    Article  CAS  PubMed  Google Scholar 

  4. Day, J. R., Jost, M., Reynolds, M. A., Groskopf, J. & Rittenhouse, H. PCA3: from basic molecular science to the clinical lab. Cancer Lett. 301, 1–6 (2011).

    Article  CAS  PubMed  Google Scholar 

  5. Ploussard, G. et al. The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies? BJU Int. 106, 1143–1147 (2010).

    Article  PubMed  Google Scholar 

  6. Auprich, M. et al. External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome. Eur. Urol. 58, 727–732 (2010).

    Article  PubMed  Google Scholar 

  7. Roobol, M. J. et al. Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test. Eur. Urol. 58, 475–481 (2010).

    Article  CAS  PubMed  Google Scholar 

  8. Haese, A. et al. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur. Urol. 54, 1081–1088 (2008).

    Article  PubMed  Google Scholar 

  9. Marks, L. S. et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology 69, 532–535 (2007).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Ms Tia Morris for editing the manuscript. The views expressed in this manuscript are those of the authors, and do not reflect the official policy of the Department of the Army, Department of Defense or the US Government.

Author information

Authors and Affiliations

  1. Department of Surgery, Urology Service, Walter Reed Army Medical Center, 6900 Georgia Avenue NW, Washington, 20307, DC, USA

    George Leighton Lee

  2. Department of Surgery, Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, 1530 E. Jefferson Street, Rockville, 20852, MD, USA

    Albert Dobi & Shiv Srivastava

Authors
  1. George Leighton Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert Dobi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shiv Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert Dobi.

Ethics declarations

Competing interests

S. Srivastava has received grant/research support from Gen-Probe. The other authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, G., Dobi, A. & Srivastava, S. Diagnostic performance of the PCA3 urine test. Nat Rev Urol 8, 123–124 (2011). https://doi.org/10.1038/nrurol.2011.10

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2011.10

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing